Detection of Matrilysin Activity Using Polypeptide Functionalized Reduced Graphene Oxide Field-Effect Transistor...

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Biochemistry

Background:

• Development of sensitive and rapid diagnostic tools for cancer biomarkers is crucial.
• Matrilysin (MMP-7) is a key biomarker implicated in various cancers.
• Existing detection methods often lack the required sensitivity or speed for early diagnosis.

Discussion:

• A novel field-effect transistor (FET) biosensor utilizing reduced graphene oxide (rGO) functionalized with a specific polypeptide (JR2EC) was developed.
• The biosensor leverages the specific digestion of JR2EC by MMP-7, leading to a measurable change in the rGO-FET conductance.
• This interaction allows for sensitive detection of MMP-7 by monitoring the electrical signal modulation.

Key Insights:

• The proposed rGO-FET assay achieved a limit of detection (LOD) of 10 ng/mL (400 pM) for MMP-7, suitable for clinical applications.
• Quantitative detection of MMP-7 in human plasma was demonstrated with an LOD of 40 ng/mL.
• The assay exhibited excellent specificity, distinguishing MMP-7 from other matrix metalloproteinases like MMP-1.

Outlook:

• The developed biosensor holds significant potential for early tumor detection and carcinoma diagnosis, including lung and salivary gland cancers.
• The platform's adaptability, through polypeptide modification, suggests its extension for detecting other enzymes with polypeptide digestion capabilities.
• Further research could optimize the sensor for broader clinical applications and multiplexed biomarker detection.